Citation Impact
Citing Papers
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
2008
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
2012
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
2004 Standout
IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
2010
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans
2009
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
2010
No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin
2007
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy
2013
IDH1andIDH2Mutations in Gliomas
2009 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas
2003
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
2008
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab
2005
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
2013
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Role of microsatellite instability in the management of colorectal cancers
2012
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
Human papillomavirus types among women infected with HIV: a meta-analysis
2006
Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
2013
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
2010
HSP90 and the chaperoning of cancer
2005 Standout
Colorectal cancer
2013 Standout
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
1991 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force
2010
A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection
2013
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
Human papillomavirus and cervical cancer
2007 Standout
Anaplastic Oligodendroglioma and Oligoastrocytoma
2007
Chronic hepatitis B
2007 Standout
Current status of genome-wide association studies in cancer
2011
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Neurological adverse effects caused by cytotoxic and targeted therapies
2009
The interaction of HIV with dendritic cells: outcomes and pathways
2007 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Oxidative Stress in Cancer
2020 Standout
Determination of microsatellite instability,p53 and K-RAS mutations in hepatic metastases from patients with colorectal cancer: Relationship with response to 5-fluorouracil and survival
2001
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Genetic mechanisms of hepatocarcinogenesis
2002
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Primary brain tumours in adults
2012 Standout
The molecular landscape of head and neck cancer
2018 Standout
Era of universal testing of microsatellite instability in colorectal cancer
2013
Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver
2012
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
2008
The genetics of the p53 pathway, apoptosis and cancer therapy
2008
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
1998 Standout
High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010
Diagnosis and Treatment of High-Grade Astrocytoma
2007
The first 30 years of p53: growing ever more complex
2009 Standout
Oncogenic pathways and the electron transport chain: a dangeROS liaison
2019
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma
2007
Hepatitis B Virus Biology
2000
Simian Immunodeficiency Virus Infection in Neonatal Macaques
2003
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
Ubiquitination and Proteasomal Degradation of Nucleophosmin-Anaplastic Lymphoma Kinase Induced by 17-Allylamino-Demethoxygeldanamycin
2004
A Single Nucleotide Polymorphism in the MDM2 Gene Disrupts the Oscillation of p53 and MDM2 Levels in Cells
2007
End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
2009
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
1995
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Human Papillomavirus and Cervical Cancer
2003 Standout
Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic Lesions
2000 Standout
DC-SIGN from African Green Monkeys Is Expressed in Lymph Nodes and Mediates Infection intransof Simian Immunodeficiency Virus SIVagm
2003 StandoutNobel
Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions
2007
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma
2017
MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
2009
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compoundCCR5polymorphisms
2003
Works of Roberta Bertorelle being referenced
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
2017
Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers
2010
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
2008
Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma
2013
Association of p53 Gene and Protein Alterations with Metastases in Colorectal Cancer
1995
Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival
1998
Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome
2007
Serum arylesterase (paraoxonase) activity following myocardial infarction
1989
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
2006
Association Between MDM2–SNP309 and Age at Colorectal Cancer Diagnosis According to p53 Mutation Status
2006
Polymorphisms in the CCR5 Promoter Region Influence Disease Progression in Perinatally Human Immunodeficiency Virus Type 1–Infected Children
2001
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene
2009
Hepatitis C virus infection associated with human hepatocellular carcinoma
1998
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study
2006
Genital Human Papillomavirus Types in Immunocompetent and Immunodepressed Women in Northeast Italy: Prevalence and Cytomorphological Correlations
2001
A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease.
1994
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
2008
Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients
2008
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors
2009
Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV-negative women.
2000